CAD 0.07
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 96.79 Million CAD | 3.33% |
2022 | 93.66 Million CAD | 24.57% |
2021 | 75.19 Million CAD | 35.97% |
2020 | 55.3 Million CAD | 13.65% |
2019 | 48.66 Million CAD | 240.11% |
2018 | 14.3 Million CAD | 18319.53% |
2017 | 77.67 Thousand CAD | 35.04% |
2016 | 57.51 Thousand CAD | 89.71% |
2015 | 30.31 Thousand CAD | 13.44% |
2014 | 26.72 Thousand CAD | -80.32% |
2013 | 135.79 Thousand CAD | 68.62% |
2012 | 80.53 Thousand CAD | 66.37% |
2011 | 48.4 Thousand CAD | -69.03% |
2010 | 156.29 Thousand CAD | -85.17% |
2009 | 1.05 Million CAD | -37.07% |
2008 | 1.67 Million CAD | -9.99% |
2007 | 1.86 Million CAD | 19.89% |
2006 | 1.55 Million CAD | -4.08% |
2005 | 1.61 Million CAD | 838.21% |
2004 | 172.44 Thousand CAD | 2690.76% |
2003 | 6179.00 CAD | -40.56% |
2002 | 10.39 Thousand CAD | 80.91% |
2001 | 5746.00 CAD | 1.79% |
2000 | 5645.00 CAD | -97.11% |
1999 | 195.05 Thousand CAD | 84.2% |
1998 | 105.89 Thousand CAD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 87.72 Million CAD | -6.87% |
2024 Q1 | 94.19 Million CAD | -2.68% |
2023 Q3 | 97.73 Million CAD | 8.65% |
2023 FY | 96.79 Million CAD | 3.33% |
2023 Q2 | 89.95 Million CAD | -5.38% |
2023 Q1 | 95.06 Million CAD | 1.49% |
2023 Q4 | 96.79 Million CAD | -0.97% |
2022 Q4 | 93.66 Million CAD | 1.15% |
2022 Q1 | 83.34 Million CAD | 10.84% |
2022 Q2 | 85.78 Million CAD | 2.92% |
2022 FY | 93.66 Million CAD | 24.57% |
2022 Q3 | 92.6 Million CAD | 7.96% |
2021 Q2 | 66.23 Million CAD | 12.26% |
2021 Q1 | 59 Million CAD | 6.69% |
2021 FY | 75.19 Million CAD | 35.97% |
2021 Q4 | 75.19 Million CAD | 5.6% |
2021 Q3 | 71.2 Million CAD | 7.5% |
2020 Q1 | 48.13 Million CAD | -1.08% |
2020 Q4 | 55.3 Million CAD | 11.78% |
2020 Q3 | 49.47 Million CAD | -0.95% |
2020 FY | 55.3 Million CAD | 13.65% |
2020 Q2 | 49.94 Million CAD | 3.77% |
2019 Q2 | 29.84 Million CAD | 100.59% |
2019 Q1 | 14.87 Million CAD | 0.0% |
2019 FY | 48.66 Million CAD | 240.11% |
2019 Q4 | 48.66 Million CAD | 31.65% |
2019 Q3 | 36.96 Million CAD | 23.85% |
2018 Q2 | 101.39 Thousand CAD | 129.19% |
2018 Q3 | 43.24 Thousand CAD | -57.35% |
2018 Q1 | 44.24 Thousand CAD | -70.9% |
2018 FY | 14.3 Million CAD | 18319.53% |
2017 Q2 | 77.67 Thousand CAD | 7.07% |
2017 Q4 | 152.04 Thousand CAD | 90.15% |
2017 FY | 77.67 Thousand CAD | 35.04% |
2017 Q1 | 72.54 Thousand CAD | 2.75% |
2017 Q3 | 79.96 Thousand CAD | 2.94% |
2016 Q4 | 70.59 Thousand CAD | 5.54% |
2016 FY | 57.51 Thousand CAD | 89.71% |
2016 Q3 | 66.89 Thousand CAD | 16.3% |
2016 Q2 | 57.51 Thousand CAD | 14.74% |
2016 Q1 | 50.12 Thousand CAD | 5.98% |
2015 Q3 | 43.3 Thousand CAD | 42.82% |
2015 Q4 | 47.29 Thousand CAD | 9.23% |
2015 Q2 | 30.31 Thousand CAD | 25.16% |
2015 Q1 | 24.22 Thousand CAD | 8.99% |
2015 FY | 30.31 Thousand CAD | 13.44% |
2014 Q3 | 32.03 Thousand CAD | 19.86% |
2014 Q2 | 26.72 Thousand CAD | -78.48% |
2014 FY | 26.72 Thousand CAD | -80.32% |
2014 Q1 | 124.22 Thousand CAD | 71.68% |
2014 Q4 | 22.22 Thousand CAD | -30.62% |
2013 Q2 | 135.79 Thousand CAD | 1.48% |
2013 Q1 | 133.8 Thousand CAD | 21.12% |
2013 Q3 | 29.44 Thousand CAD | -78.32% |
2013 Q4 | 72.35 Thousand CAD | 145.73% |
2013 FY | 135.79 Thousand CAD | 68.62% |
2012 Q3 | 103.65 Thousand CAD | 28.71% |
2012 Q4 | 110.47 Thousand CAD | 6.58% |
2012 FY | 80.53 Thousand CAD | 66.37% |
2012 Q1 | 56.38 Thousand CAD | 14.61% |
2012 Q2 | 80.53 Thousand CAD | 42.84% |
2011 Q3 | 33.41 Thousand CAD | -30.97% |
2011 Q4 | 49.19 Thousand CAD | 47.21% |
2011 FY | 48.4 Thousand CAD | -69.03% |
2011 Q1 | 34.32 Thousand CAD | -53.88% |
2011 Q2 | 48.4 Thousand CAD | 41.03% |
2010 Q3 | 46.73 Thousand CAD | -70.1% |
2010 Q4 | 74.41 Thousand CAD | 59.24% |
2010 FY | 156.29 Thousand CAD | -85.17% |
2010 Q2 | 156.29 Thousand CAD | -7.49% |
2010 Q1 | 168.93 Thousand CAD | 141.64% |
2009 Q2 | 1.05 Million CAD | 1.29% |
2009 FY | 1.05 Million CAD | -37.07% |
2009 Q4 | 69.91 Thousand CAD | -94.0% |
2009 Q1 | 1.04 Million CAD | -24.48% |
2009 Q3 | 1.16 Million CAD | 10.61% |
2008 Q2 | 1.67 Million CAD | -15.74% |
2008 Q4 | 1.37 Million CAD | -0.56% |
2008 Q3 | 1.38 Million CAD | -17.27% |
2008 Q1 | 1.98 Million CAD | 4.93% |
2008 FY | 1.67 Million CAD | -9.99% |
2007 Q1 | 935.93 Thousand CAD | 7.94% |
2007 Q4 | 1.89 Million CAD | 1.55% |
2007 Q3 | 1.86 Million CAD | 0.26% |
2007 Q2 | 1.86 Million CAD | 98.8% |
2007 FY | 1.86 Million CAD | 19.89% |
2006 Q2 | 1.55 Million CAD | -5.88% |
2006 Q3 | 1.59 Million CAD | 2.99% |
2006 Q1 | 1.64 Million CAD | 2.89% |
2006 Q4 | 867.08 Thousand CAD | -45.75% |
2006 FY | 1.55 Million CAD | -4.08% |
2005 Q3 | 1.56 Million CAD | -3.06% |
2005 Q2 | 1.61 Million CAD | -4.37% |
2005 FY | 1.61 Million CAD | 838.21% |
2005 Q4 | 1.6 Million CAD | 2.18% |
2005 Q1 | 1.69 Million CAD | 0.56% |
2004 Q1 | 105.83 Thousand CAD | -26.78% |
2004 Q2 | 172.44 Thousand CAD | 62.93% |
2004 Q4 | 1.68 Million CAD | 1174.73% |
2004 FY | 172.44 Thousand CAD | 2690.76% |
2004 Q3 | 131.97 Thousand CAD | -23.47% |
2003 FY | 6179.00 CAD | -40.56% |
2003 Q4 | 144.54 Thousand CAD | 1.11% |
2003 Q3 | 142.95 Thousand CAD | 2213.55% |
2003 Q2 | 6179.00 CAD | -55.93% |
2003 Q1 | 14.02 Thousand CAD | 15.97% |
2002 Q4 | 12.08 Thousand CAD | -24.4% |
2002 Q3 | 15.99 Thousand CAD | 53.83% |
2002 Q2 | 10.39 Thousand CAD | 20.59% |
2002 FY | 10.39 Thousand CAD | 80.91% |
2002 Q1 | 8620.00 CAD | 68.89% |
2001 Q1 | 4997.00 CAD | 0.0% |
2001 FY | 5746.00 CAD | 1.79% |
2001 Q4 | 5104.00 CAD | -62.35% |
2001 Q3 | 13.55 Thousand CAD | 135.92% |
2001 Q2 | 5746.00 CAD | 14.99% |
2000 Q2 | 5645.00 CAD | 0.0% |
2000 FY | 5645.00 CAD | -97.11% |
2000 Q3 | 8616.00 CAD | 52.63% |
1999 Q3 | 210.87 Thousand CAD | 0.0% |
1999 FY | 195.05 Thousand CAD | 84.2% |
1998 FY | 105.89 Thousand CAD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Aequus Pharmaceuticals Inc. | 5.38 Million CAD | -1699.067% |
CanadaBis Capital Inc. | 15.61 Million CAD | -519.705% |
Delivra Health Brands Inc. | 4.85 Million CAD | -1892.404% |
Entourage Health Corp. | 178.68 Million CAD | 45.832% |
Lifeist Wellness Inc. | 9.94 Million CAD | -873.686% |
Cannara Biotech Inc. | 61.77 Million CAD | -56.675% |
Medicure Inc. | 8.16 Million CAD | -1085.728% |
PharmaCielo Ltd. | 23.96 Million CAD | -303.817% |
Rubicon Organics Inc. | 16.99 Million CAD | -469.469% |
BioSyent Inc. | 6.76 Million CAD | -1329.877% |
Voyageur Pharmaceuticals Ltd. | 727.87 Thousand CAD | -13197.714% |